• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of complement components of the alternative pathway by glioma cell lines.

作者信息

Gasque P, Julen N, Ischenko A M, Picot C, Mauger C, Chauzy C, Ripoche J, Fontaine M

机构信息

European Institute for Peptide Research INSERM U-78, Bois-Guillaume, France.

出版信息

J Immunol. 1992 Aug 15;149(4):1381-7.

PMID:1386864
Abstract

Glioma cell lines express proteins of the complement alternative pathway, namely C3, factor B, factor H, and factor I. Secretion of these proteins was shown by a sensitive and specific ELISA. C3 and factor H were rapidly secreted by glioma cell line CB193 and reached a concentration of 140 ng/ml/10(6) cells after 72 h of culture. Factor B and factor I were secreted at a lower rate and reached concentrations of 25 and 15 ng/ml/10(6) cells, respectively. Western blot and immunoprecipitation experiments showed that secreted proteins were identical to the corresponding plasma proteins. For factor H, besides the well known 150-kDa species, an additional polypeptide of 45 kDa with factor H immunoreactivity was observed. This species corresponded to the N-terminal truncated form found in plasma. In preliminary experiments, we observed control of these syntheses by cytokines. IL-1 beta significantly increased C3 secretion, with no effect on factor H. Secretion of factor H was enhanced by IFN-gamma. These results show that a glioma cell line could be a useful tool to study complement biosynthesis by glial cells in humans.

摘要

相似文献

1
Expression of complement components of the alternative pathway by glioma cell lines.
J Immunol. 1992 Aug 15;149(4):1381-7.
2
Differential modulation by glucocorticoids of alternative complement protein secretion in cells of the monocyte/macrophage lineage.
Eur J Immunol. 1992 Apr;22(4):909-15. doi: 10.1002/eji.1830220405.
3
Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I.人成肌细胞在体外补体替代途径的表达:C3、B因子、H因子和I因子的生物合成
Eur J Immunol. 1995 Dec;25(12):3460-6. doi: 10.1002/eji.1830251238.
4
Expression of complement alternative pathway proteins by endothelial cells. Differential regulation by interleukin 1 and glucocorticoids.内皮细胞中补体替代途径蛋白的表达。白细胞介素1和糖皮质激素的差异调节。
Eur J Immunol. 1990 Aug;20(8):1669-75. doi: 10.1002/eji.1830200808.
5
Secretion of complement components of the alternative pathway (C3 and factor B) by the human alveolar type II epithelial cell line A549.人肺泡II型上皮细胞系A549分泌替代途径的补体成分(C3和B因子)。
Int J Mol Med. 2000 Apr;5(4):415-9. doi: 10.3892/ijmm.5.4.415.
6
Effect of interferon-gamma on complement gene expression in different cell types.干扰素-γ对不同细胞类型中补体基因表达的影响。
Biochem J. 1992 Jan 15;281 ( Pt 2)(Pt 2):437-42. doi: 10.1042/bj2810437.
7
Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1.干扰素-γ和白细胞介素-1对人脐静脉内皮细胞中补体因子H和C3产生的差异调节
J Immunol. 1990 May 15;144(10):3835-40.
8
Metabolism of C3 and factor B in patients with congenital factor I deficiency.先天性因子I缺乏症患者中C3和因子B的代谢
J Clin Lab Immunol. 1990 Feb;31(2):59-67.
9
IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts.白细胞介素-1与肿瘤坏死因子。人成纤维细胞中补体替代途径及干扰素-β2/白细胞介素-6基因表达刺激方面的异同
J Immunol. 1989 Jun 1;142(11):3862-7.
10
Differential modulation of complement factor H and C3 expression by TNF-alpha in the rat. In vitro and in vivo studies.肿瘤坏死因子-α对大鼠补体因子H和C3表达的差异调节:体外和体内研究
Mol Immunol. 1992 Jul-Aug;29(7-8):983-8. doi: 10.1016/0161-5890(92)90137-m.

引用本文的文献

1
The complement system in neurodegenerative diseases.补体系统与神经退行性疾病。
Clin Sci (Lond). 2024 Mar 20;138(6):387-412. doi: 10.1042/CS20230513.
2
Complement Activation and Up-Regulated Expression of Anaphylatoxin C3a/C3aR in Glioblastoma: Deciphering the Links with TGF-β and VEGF.胶质母细胞瘤中补体激活及过敏毒素C3a/C3aR的表达上调:解读与转化生长因子-β和血管内皮生长因子的联系
Cancers (Basel). 2023 May 7;15(9):2647. doi: 10.3390/cancers15092647.
3
Complement System in Alzheimer's Disease.补体系统与阿尔茨海默病。
Int J Mol Sci. 2021 Dec 20;22(24):13647. doi: 10.3390/ijms222413647.
4
Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury.靶向补体 C3a 受体改善缺血性脑损伤的预后。
Neurochem Res. 2021 Oct;46(10):2626-2637. doi: 10.1007/s11064-021-03419-6. Epub 2021 Aug 11.
5
An "Outside-In" and "Inside-Out" Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases.对多发性硬化症大脑中补体的“由外向内”和“由内向外”的思考:来自发育和神经退行性疾病的经验教训。
Front Cell Neurosci. 2021 Jan 7;14:600656. doi: 10.3389/fncel.2020.600656. eCollection 2020.
6
Drivers and regulators of humoral innate immune responses to infection and cancer.体液固有免疫应答在感染和癌症中的驱动因素和调节因子。
Mol Immunol. 2020 May;121:99-110. doi: 10.1016/j.molimm.2020.03.005. Epub 2020 Mar 18.
7
Proteomic analysis of cerebrospinal fluid in pediatric acute lymphoblastic leukemia patients: a pilot study.小儿急性淋巴细胞白血病患者脑脊液的蛋白质组学分析:一项初步研究。
Onco Targets Ther. 2019 May 17;12:3859-3868. doi: 10.2147/OTT.S193616. eCollection 2019.
8
Human brain trauma severity is associated with lectin complement pathway activation.人类脑创伤严重程度与凝集素补体途径的激活有关。
J Cereb Blood Flow Metab. 2019 May;39(5):794-807. doi: 10.1177/0271678X18758881. Epub 2018 Feb 9.
9
CD59 mediates cartilage patterning during spontaneous tail regeneration.CD59在自发尾部再生过程中介导软骨模式形成。
Sci Rep. 2015 Aug 4;5:12798. doi: 10.1038/srep12798.
10
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.补体因子I在乳腺癌细胞中的局部表达与较差的生存率和复发率相关。
Cancer Immunol Immunother. 2015 Apr;64(4):467-78. doi: 10.1007/s00262-015-1658-8. Epub 2015 Jan 25.